Curaxis Pharmaceutical Corp. Management on Roadshow in Europe to Access Capital & Pursue Strategic Partners

DURHAM, N.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp (OTCBB:CURX), confirmed today that Curaxis Management will be in Europe for the first part of February. Curaxis has been approved to trade on the Frankfurt stock exchange ("FSE") under the symbol 8CX to expand its global capital markets access. Along with its U.S. investment bankers, Curaxis has engaged a European Advisor, Continental Advisors, to complement its European capital markets initiatives as well as explore further business development or European strategic partnerships.